Table 1.
Bacterial strains used in this study
| Strain | Description | Reference |
|---|---|---|
| R6 | unencapsulated WT strain, ATCC BAA255 | 27 |
| M168 | reserpine-resistant mutant derived from M4 | 7 |
| M184 | reserpine-resistant mutant derived from R6 | 7 |
| M87 | clinical isolate from MRL Pharmaceutical Services | 28 |
| M101 | clinical isolate from MRL Pharmaceutical Services | 28 |
| M505 | R6 recipient transformed with M101 DNA, selected on 8 mg/L ethidium bromide | this study |
| M506 | R6 recipient transformed with M187 DNA, selected on 8 mg/L ethidium bromide | this study |
| M507 | R6 recipient transformed with M174 DNA, selected on 8 mg/L ethidium bromide | this study |
| M511 | R6 containing pBAV1K-gfp82 vector | this study |
| M512 | R6 containing construct pBAV1K-gfp82-WT | this study |
| M513 | R6 containing construct pBAV1K-gfp82-v101 | this study |
| M514 | R6 containing construct pBAV1K-gfp82-v101c | this study |
| M517 | R6 containing construct pBAV1K-gfp82-v168 | this study |
| M518 | R6 containing construct pBAV1K-gfp82-v168c | this study |
| M515 | R6 containing construct pBAV1K-gfp82-v87 | this study |
| M516 | R6 containing construct pBAV1K-gfp82-v87c | this study |